Sign up
Matches 1 - 50 out of 421 1 2 3 4 5 6 7 8 9 >


Match Document Document Title
US20110151005 METHODS AND MEANS FOR SOFT TISSUE ENGINEERING  
Cellfree adipose tissue extracts, implants including the same and methods for the preparation thereof. The extracts and implants are capable of inducing adipogenesis and angiogenesis and are, thus,...
US20110311608 STABLE CHITOSAN HEMOSTATIC IMPLANT AND METHODS OF MANUFACTURE  
Implantable hemostatic products with improved stability are prepared from crosslinked chitosan hemostatic compositions. The crosslinked chitosan hemostatic compositions have improved stability and...
US20120148671 GASTRIC RETAINED GABAPENTIN DOSAGE FORM  
A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form.
US20110002999 Biopolymer System for Tissue Sealing  
A tissue sealant for use in surgical and medical procedures for sealing the tissues of a living mammal is provided. The tissue sealant comprises a hydrogel which is formed by gelation of a premix...
US20120114754 RAPIDLY DISINTEGRATING SOLID ORAL DOSAGE FORM  
Disclosed is a rapidly disintegrating solid oral dosage form of a poorly soluble active ingredient and at least one pharmaceutically acceptable water-soluble or water-dispersible excipient, wherein...
US20110229574 POLYSACCHARIDE AND PROTEIN-POLYSACCHARIDE CROSS-LINKED HYDROGELS FOR SOFT TISSUE AUGMENTATION  
Disclosed herein are cohesive soft tissue fillers, for example, dermal and subdermal fillers, based on hyaluronic acids and optionally including proteins. In one aspect, hyaluronic acid-based...
US20110142939 Use of a Combination of an Opioid Agonist and an Opioid Antagonist for the Treatment of Crohn's Disease and the Symptoms Associated with Crohn's Disease  
The present invention is concerned with the use of combinations of opioid agonists and antagonists for treating Crohn's disease.
US20130302420 OCULAR BIODEGRADABLE DRUG IMPLANT AND METHOD OF ITS USE  
A biodegradable drug implant includes a PLG matrix and a non-steroid anti inflammation drug, for example diclofenac sodium. The implant is inserted into the eye in the anterior chamber, for example...
US20120294938 PHARMACEUTICAL PREPARATION FOR ORAL ADMINISTRATION WITH CONTROLLED ACTIVE INGREDIENT RELEASE IN THE SMALL INTESTINE AND METHOD FOR ITS PRODUCTION  
Any pharmaceutical preparation for oral administration with controlled release of active ingredient in the small bowel, on the basis of active ingredient carriers provided with at least one active...
US20110020452 PROGENITOR CELL REPLICATION AND DIFFERENTIATION IN 3D  
The present invention is directed to a new approach towards in situ differentiation of tissue progenitor cells, without the coventional requirements of weeks of cellular manipulation and treatment....
US20120231075 ABUSE-RESISTANT OPIOID DOSAGE FORM  
We provide a pharmaceutical dosage form including an opioid antagonist surrounded by a controlled release matrix and an opioid agonist in a surrounding matrix.
US20110020444 ABUSE-RESISTANT OPIOID DOSAGE FORM  
We provide a pharmaceutical dosage form including an opioid antagonist surrounded by a controlled release matrix and an opioid agonist in a surrounding matrix.
US20120282340 DRUG DELIVERY SYSTEM  
The present invention relates to drug delivery systems in the form of thin water-soluble films (wafers), which contain an Estrogen Receptor beta (ER-β) selective agonist. The wafers of the present ...
US20110236454 INJECTABLE DRUG DELIVERY FORMULATION  
The invention provides an injectable formulation that includes an active agent; a biocompatible solvent system, crosslinkable polymers such as polysaccharides; and crosslinking agents; wherein the...
US20120263788 CONTROLLED RELEASE HYDROCODONE FORMULATIONS  
A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof,...
US20100297239 OSSEOINTEGRATIVE MENISCUS AND CARTILAGE IMPLANTS BASED ON BETA-GLUCAN NANOCOMPOSITES  
The present invention provides engineered composite materials for use in medical treatment of injured or degenerated menisci, cartilage, and bone. The composite materials include a cellulosic layer...
US20110190688 Permeant Delivery System and Methods for Use Thereof  
Disclosed are a patch, system, and method for delivery of a permeant composition into a subject via at least one formed pathway through a biological membrane of the subject. The patch comprises a...
US20050158388 Treatment of gynecomastia with 4-hydroxy tamoxifen  
The present invention provides methods for treating and preventing gynecomastia by administering 4-hydroxy tamoxifen to a patient. When percutaneously administered to a patient's breasts, 4-hydroxy...
US20140199394 CONTROLLED RELEASE HYDROCODONE  
A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof,...
US20110052685 GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR IMMEDIATE AND EXTENDED RELEASE OF ACETAMINOPHEN  
Gastric retentive dosage forms for extended release of acetaminophen or for both immediate and extended release of acetaminophen are described. The dosage forms allow effective pain relief upon...
US20110293720 PROGESTIN-CONTAINING DRUG DELIVERY SYSTEM  
The present invention relates to drug delivery compositions in the form of thin water-soluble films (wafers), which contain small particles that comprise at least one progestin and at least one...
US20110014290 SYSTEM AND METHOD FOR FACILITATING HEMOSTASIS WITH AN ABSORBABLE SPONGE  
The present invention provides for a method and apparatus to provide hemostasis at a blood vessel puncture site, having a hemostasis material and a clot formation accelerator, wherein said clot...
US20120107383 OSTEOCONDUCTIVE MATRICES COMPRISING CALCIUM PHOSPHATE PARTICLES AND STATINS AND METHODS OF USING THE SAME  
Osteoconductive matrices and methods are provided that have one or more statins disposed in calcium phosphate particles. The matrices may be injected into a fracture site. The osteoconductive...
US20110097405 ESTRADIOL-CONTAINING DRUG DELIVERY SYSTEM  
The present invention relates to drug delivery systems in the form of thin water-soluble films (wafers), which contain estradiol, or derivatives thereof, in low amounts. The wafers of the present...
US20140134250 OXYMORPHONE CONTROLLED RELEASE FORMULATIONS  
The invention pertains to a method of relieving pain by administering a controlled release pharmaceutical tablet containing oxymorphone which produces a mean minimum blood plasma level 12 to 24...
US20110117196 Analgetic dosage forms that are resistant to parenteral and inhalation dosing and have reduced side effects  
The invention provides a novel solid pharmaceutical dosage form which includes an opiate, an opiate antagonist admixed with the analgetic (opiate agonist) and an amount of a hydrocolloid containing...
US20130039981 Quick Dissolving, Long Acting Zinc Therapeutic Formulations  
The present invention comprises a quick dissolving, long acting zinc therapeutic cold formulation containing high levels of an active compound encapsulated within bioadhesive/muco-adhesive polymers...
US20130171256 ALCOHOL-RESISTANT EXTENDED RELEASE DOSAGE FORMS COMPRISING VENLAFAXINE  
This disclosure relates to an extended release oral dosage form comprising a matrix containing a viscosity modifier (but no lipid) and coated granules containing venlafaxine or a pharmaceutically...
US20140086988 Stabilized Protein Crystals, Formulations Containing Them and Methods of Making Them  
This invention relates to methods for the stabilization, storage and delivery of biologically active macromolecules, such as proteins, peptides and nucleic acids. In particular, this invention...
US20050181057 Vaginal lubricant  
A vaginal lubricant comprises (i) water, (ii) a DHEA salt, (iii) a polyether, and (iv) a lubricant. The pH of the vaginal lubricant is at least 5.6.
US20110104273 GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR IMMEDIATE AND EXTENDED RELEASE OF PHENYLEPHRINE  
Gastric retentive dosage forms for both immediate and extended release of phenylephrine are described which allow once- or twice-daily dosing. Methods of treatment using the dosage forms and...
US20130202705 ALCOHOL-RESISTANT FORMULATIONS  
This disclosure relates to an extended release oral dosage form comprising a matrix containing a viscosity modifier (but no lipid) and coated granules containing a high water-soluble, high dose...
US20120141583 ALCOHOL RESISTANT DOSAGE FORMS  
Opioid controlled release formulation resistant to alcohol extraction of the opioid.
US20130017264 ALGINATE TUBE DRUG DELIVERY SYSTEM AND METHOD THEREFOR  
A drug delivery system which comprises alginate tube that is prepared by coating a substrate with alginate gel. One or more therapeutic drugs may also be present in the alginate gel or in the...
US20110059162 TANNIN-CHITOSAN COMPOSITES  
The invention provides a composition comprising a matrix of chitosan and a tannin wherein the chitosan is electrostatically bonded to the tannin to form a chitosan-tannin composite material. The...
US20110097408 CHITOSAN-BASED MATRICES AND USES THEREOF  
This invention relates a controlled release delivery composition for an otorhinolaryngology and otorhinolaryngology-associated pathology, conditions, indications or their combination, Head and Neck...
US20110129536 NANOCOMPOSITE MATERIALS BASED ON METALLIC NANOPARTICLES STABILIZED WITH BRANCHED POLYSACCHARIDES  
The present invention provides nanocomposite systems made of metallic nanoparticles stabilized with branched cationic polysaccharides, in particular alditolic or aldonic mono- and oligo-saccharidic...
US20110027361 EXTENDED RELEASE DOSAGE FORM OF PALIPERIDONE  
The present invention relates to an extended release solid oral pharmaceutical composition comprising Paliperidone or its pharmaceutically acceptable salts and process for preparing the same.
US20130045162 DELIVERY SYSTEM FOR SPECIFICALLY TARGETING CANCER CELLS AND METHOD OF USE THEREOF  
Methods for prevention, treatment or inhibition of the growth or metastasis of cancer cells in a subject are disclosed. One method comprises the step of administering to the subject a...
US20110111033 HYDROGEL WITH COVALENTLY CROSSLINKED CORE  
A novel hydrogel system is provided. The hydrogel system comprises a biocompatible hydrogel core having dispersed therein a covalently crosslinked polymer matrix. The hydrogel system is useful per...
US20110189292 DERMAL FILLERS COMPRISING SILK FIBROIN HYDROGELS AND USES THEREOF  
The present specification provides compositions useful as dermal fillers and methods using such compositions to treat a condition of skin.
US20110171311 STABLE HYDROGEL COMPOSITIONS INCLUDING ADDITIVES  
The present specification generally relates to hydrogel compositions and methods of treating a soft tissue condition using such hydrogel compositions.
US20120009263 GRANULAR DELIVERY SYSTEM  
A granular delivery system and a method of preparing the same by creating a melt emulsion having a continuous phase and a dispersed active, wherein the continuous phase includes trehalose and a...
US20110244032 DISPERSIBLE PHOSPHOLIPID STABILIZED MICROPARTICLES  
Rapidly dispersing solid dry therapeutic dosage form comprised of a water insoluble compound existing as a nanometer or micrometer particulate solid which is surface stabilized by the presence of...
US20130189333 ORAL PRODUCT  
An oral product includes a body that is wholly receivable in an oral cavity. The body includes a mouth-stable polymer matrix, cellulosic fibers embedded in the mouth-stable polymer matrix, and an...
US20120328700 METHODS AND COMPOSITIONS FOR REGENERATING CONNECTIVE TISSUE  
Connective tissue regenerative compositions and methods of repairing and regenerating connective tissue using such compositions are provided. The compositions generally comprise a bioactive...
US20120207836 DRUG DELIVERY SYSTEMS (WAFER) FOR PEDIATRIC USE  
The present invention describes drug delivery compositions in the form of thin water-soluble films (wafers), which contain particles that comprise at least one active ingredient—which is not an e...
US20110311632 STABLE CHITOSAN HEMOSTATIC EXTERNAL PATCH AND METHODS OF MANUFACTURE  
Hemostatic products with improved stability are prepared from crosslinked chitosan hemostatic compositions. The crosslinked chitosan hemostatic compositions have improved stability and can be...
US20110150994 Modified Release Formulation  
The invention is directed to the use of an extended release tablet formulation for pramipexole.
US20110244045 CONTROLLED RELEASE OF N-ACETYLCYSTEINE (NAC) FOR REDUCTION OF SYSTEMIC AND/OR VASCULAR INFLAMMATION  
The present invention provides a controlled-release composition which provides a therapeutically effective plasma concentration of N-acetylcysteine over prolonged period of time. The present...
Matches 1 - 50 out of 421 1 2 3 4 5 6 7 8 9 >